Embla Medical hf.'s latest marketcap:
As of 07/05/2025, Embla Medical hf.'s market capitalization has reached $2.28 B. According to our data, Embla Medical hf. is the 5694th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 2.28 B |
| Revenue (ttm) | 931.29 M |
| Net Income (ttm) | 78.36 M |
| Shares Out | 426.02 M |
| EPS (ttm) | 0.18 |
| Forward PE | 26.34 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/22/2025 |
Embla Medical hf.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | kr2.28 B | -4.7% | 5694 |
| 12/30/2024 | kr15.2 B | 31.74% | 5505 |
| 12/29/2023 | kr11.54 B | -18.15% | 6191 |
| 12/30/2022 | kr14.1 B | -21.07% | 5328 |
| 12/30/2021 | kr17.86 B | -12.64% | 5054 |
| 12/30/2020 | kr20.44 B | -7.38% | 3840 |
| 12/30/2019 | kr22.07 B | 67.34% | 3267 |
| 12/28/2018 | kr13.19 B | 15.8% | 3987 |
| 12/29/2017 | kr11.39 B | 3.61% | 4861 |
| 12/30/2016 | kr10.99 B | 4.62% | 4733 |
Company Profile
About Embla Medical hf.
Embla Medical hf., along with its subsidiaries, specializes in non-invasive orthopedic products, serving markets across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Business Segments
- Prosthetics and Neuro Orthotics: Offers mechanical and bionic products, including microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints for lower and upper limb support.
- Bracing and Supports: Provides spinal, hip, knee, foot, ankle, and hand support devices, along with injury recovery solutions for fractures, post-operative care, and ligament injuries.
- Patient Care: Delivers prosthetics for limb loss or difference and orthotics for neurological, gait, and musculoskeletal conditions.
Customer Base
The company serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers.
Distribution
Embla Medical hf. sells its products through a direct sales network and distributors.
Corporate Background
Originally founded in 1971 as Össur hf., the company rebranded as Embla Medical hf. in April 2024. Headquartered in Reykjavik, Iceland, it operates as a subsidiary of William Demant Invest A/S.
Frequently Asked Questions
-
What is Embla Medical hf.'s (CPH-EMBLA) current market cap?As of 07/05/2025, Embla Medical hf. (including the parent company, if applicable) has an estimated market capitalization of $2.28 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Embla Medical hf. (CPH-EMBLA) rank globally by market cap?Embla Medical hf. global market capitalization ranking is approximately 5694 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.